Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 1/2019

20.10.2018 | Original Article – Cancer Research

G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail

verfasst von: Zhen Wang, Xiao Chen, Yongqiang Zhao, Yi Jin, Jia Zheng

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Emerging evidences show that G-protein-coupled estrogen receptor (GPER) can regulate the progression of various cancers, while its roles in the progression of osteosarcoma (OS) are not well illustrated.

Methods

The expression of GPER in OS cells and tissues were checked. Its roles in cell migration and expression of Snail was checked by use of its agonist G-1.

Results

We found that the expression of GPER in OS cells and tissues were lower than that in their corresponding controls. OS patients with higher levels of GPER showed increased overall survival rate (OS) as compared with the lower ones. The activator of GPER (G-1) or overexpression of GPER can inhibit the migration and invasion of OS cells and downregulate mesenchymal markers. G-1 can rapidly decrease the expression of Snail, one powerful epithelial–mesenchymal transition transcription factor (EMT-TF). Overexpression of Snail can attenuate the suppression effects of G-1 on migration of OS cells, suggesting that Snail was involved in GPER-regulated migration of OS cells. Mechanically, G-1 rapidly decreased the protein of Snail but had no effect on its mRNA expression. This was because G-1 can decrease the protein stability of Snail. Further, G-1 increased the expression of FBXL5, which can trigger the proteasome-mediated degradation of Snail. Knockdown of FBXL5 can reverse G-1-induced downregulation of Snail in OS cells.

Conclusion

Activation of GPER can suppress the migration and invasion of OS cells via FBXL5-mediated post-translational down regulation of Snail. It suggested that targeted activation of GPER might be a potent potential therapy approach to overcome the metastasis of OS patients.
Literatur
Zurück zum Zitat Anderson ME (2016) Update on survival in osteosarcoma. Orthop Clin N Am 47:283–292CrossRef Anderson ME (2016) Update on survival in osteosarcoma. Orthop Clin N Am 47:283–292CrossRef
Zurück zum Zitat Azmi AS, Muqbil I, Wu J, Aboukameel A, Senapedis W, Baloglu E, Bollig-Fischer A, Dyson G, Kauffman M, Landesman Y et al (2015) Targeting the nuclear export protein XPO1/CRM1 reverses epithelial to mesenchymal transition. Sci Rep 5:16077CrossRefPubMedPubMedCentral Azmi AS, Muqbil I, Wu J, Aboukameel A, Senapedis W, Baloglu E, Bollig-Fischer A, Dyson G, Kauffman M, Landesman Y et al (2015) Targeting the nuclear export protein XPO1/CRM1 reverses epithelial to mesenchymal transition. Sci Rep 5:16077CrossRefPubMedPubMedCentral
Zurück zum Zitat Brabletz T, Kalluri R, Nieto MA, Weinberg RA (2018) EMT in cancer. Nat Rev Cancer 18:128–128+CrossRefPubMed Brabletz T, Kalluri R, Nieto MA, Weinberg RA (2018) EMT in cancer. Nat Rev Cancer 18:128–128+CrossRefPubMed
Zurück zum Zitat Bustos V, Nolan AM, Nijhuis A, Harvey H, Parker A, Poulsom R, McBryan J, Thomas W, Silver A, Harvey BJ (2017) GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget 8:84258–84275CrossRefPubMedPubMedCentral Bustos V, Nolan AM, Nijhuis A, Harvey H, Parker A, Poulsom R, McBryan J, Thomas W, Silver A, Harvey BJ (2017) GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget 8:84258–84275CrossRefPubMedPubMedCentral
Zurück zum Zitat Chen P, Wang H, Duan Z, Zou JX, Chen H, He W, Wang J (2014) Estrogen-related receptor alpha confers methotrexate resistance via attenuation of reactive oxygen species production and P53 mediated apoptosis in osteosarcoma cells. Biomed Res Int 2014:616025PubMedPubMedCentral Chen P, Wang H, Duan Z, Zou JX, Chen H, He W, Wang J (2014) Estrogen-related receptor alpha confers methotrexate resistance via attenuation of reactive oxygen species production and P53 mediated apoptosis in osteosarcoma cells. Biomed Res Int 2014:616025PubMedPubMedCentral
Zurück zum Zitat Chen Y, Zhang K, Li Y, He Q (2017) Estrogen-related receptor alpha participates transforming growth factor-beta (TGF-beta) induced epithelial-mesenchymal transition of osteosarcoma cells. Cell Adhes Migr 11:338–346CrossRef Chen Y, Zhang K, Li Y, He Q (2017) Estrogen-related receptor alpha participates transforming growth factor-beta (TGF-beta) induced epithelial-mesenchymal transition of osteosarcoma cells. Cell Adhes Migr 11:338–346CrossRef
Zurück zum Zitat Chou AJ, Geller DS, Gorlick R (2008) Therapy for osteosarcoma: where do we go from here? Paediatr Drugs 10:315–327CrossRefPubMed Chou AJ, Geller DS, Gorlick R (2008) Therapy for osteosarcoma: where do we go from here? Paediatr Drugs 10:315–327CrossRefPubMed
Zurück zum Zitat Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, Meyers PA, Huh WW (2015) Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer 112:278–282CrossRefPubMed Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, Meyers PA, Huh WW (2015) Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer 112:278–282CrossRefPubMed
Zurück zum Zitat Fang D, Yang H, Lin J, Teng Y, Jiang Y, Chen J, Li Y (2015) 17beta-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner. Biochem Biophys Res Commun 457:500–506CrossRefPubMed Fang D, Yang H, Lin J, Teng Y, Jiang Y, Chen J, Li Y (2015) 17beta-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner. Biochem Biophys Res Commun 457:500–506CrossRefPubMed
Zurück zum Zitat Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, Guo W, Xia K, Liu G (2016) Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett 12:5007–5014CrossRefPubMedPubMedCentral Fang S, Yu L, Mei H, Yang J, Gao T, Cheng A, Guo W, Xia K, Liu G (2016) Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail. Oncol Lett 12:5007–5014CrossRefPubMedPubMedCentral
Zurück zum Zitat Feldman RD, Ding Q, Hussain Y, Limbird LE, Pickering JG, Gros R (2016) Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER). FASEB J 30:2086–2096CrossRefPubMed Feldman RD, Ding Q, Hussain Y, Limbird LE, Pickering JG, Gros R (2016) Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER). FASEB J 30:2086–2096CrossRefPubMed
Zurück zum Zitat Fic A, Mlakar SJ, Juvan P, Mlakar V, Marc J, Dolenc MS, Broberg K, Masic LP (2015) Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S. Toxicol In Vitro 29:1060–1069CrossRefPubMed Fic A, Mlakar SJ, Juvan P, Mlakar V, Marc J, Dolenc MS, Broberg K, Masic LP (2015) Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma cells to bisphenol A and its analogs bisphenols AF and S. Toxicol In Vitro 29:1060–1069CrossRefPubMed
Zurück zum Zitat Filardo EJ (2018) A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: dysregulated glandular homeostasis, survival and metastasis. J Steroid Biochem Mol Biol 176:38–48CrossRefPubMed Filardo EJ (2018) A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: dysregulated glandular homeostasis, survival and metastasis. J Steroid Biochem Mol Biol 176:38–48CrossRefPubMed
Zurück zum Zitat Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol (Baltim MD) 14:1649–1660CrossRef Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol (Baltim MD) 14:1649–1660CrossRef
Zurück zum Zitat Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M (2015) Advances in emerging drugs for osteosarcoma. Expert Opin Emerg Drugs 20:495–514CrossRefPubMed Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M (2015) Advances in emerging drugs for osteosarcoma. Expert Opin Emerg Drugs 20:495–514CrossRefPubMed
Zurück zum Zitat Kansara M, Teng MW, Smyth MJ, Thomas DM (2014) Translational biology of osteosarcoma. Nat Rev Cancer 14:722–735CrossRefPubMed Kansara M, Teng MW, Smyth MJ, Thomas DM (2014) Translational biology of osteosarcoma. Nat Rev Cancer 14:722–735CrossRefPubMed
Zurück zum Zitat Liang S, Chen Z, Jiang G, Zhou Y, Liu Q, Su Q, Wei W, Du J, Wang H (2017) Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-kappaB/IL-6 signals. Cancer Lett 386:12–23CrossRefPubMed Liang S, Chen Z, Jiang G, Zhou Y, Liu Q, Su Q, Wei W, Du J, Wang H (2017) Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-kappaB/IL-6 signals. Cancer Lett 386:12–23CrossRefPubMed
Zurück zum Zitat Maggiolini M, Picard D (2010) The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204:105–114CrossRefPubMed Maggiolini M, Picard D (2010) The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204:105–114CrossRefPubMed
Zurück zum Zitat Marjon NA, Hu C, Hathaway HJ, Prossnitz ER (2014) G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis. Mol Cancer Res 12:1644–1654CrossRefPubMedPubMedCentral Marjon NA, Hu C, Hathaway HJ, Prossnitz ER (2014) G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis. Mol Cancer Res 12:1644–1654CrossRefPubMedPubMedCentral
Zurück zum Zitat Meazza C, Scanagatta P (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer 16:543–556CrossRef Meazza C, Scanagatta P (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Rev Anticancer 16:543–556CrossRef
Zurück zum Zitat Meng X, Zhu Y, Tao L, Zhao S, Qiu S (2018) miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19. Mol Med Rep 17:7202–7208PubMedPubMedCentral Meng X, Zhu Y, Tao L, Zhao S, Qiu S (2018) miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19. Mol Med Rep 17:7202–7208PubMedPubMedCentral
Zurück zum Zitat Molina L, Figueroa CD, Bhoola KD, Ehrenfeld P (2017) GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer. Expert Opin Ther Targets 21:755–766CrossRefPubMed Molina L, Figueroa CD, Bhoola KD, Ehrenfeld P (2017) GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer. Expert Opin Ther Targets 21:755–766CrossRefPubMed
Zurück zum Zitat Nieto MA (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3:155–166CrossRefPubMed Nieto MA (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3:155–166CrossRefPubMed
Zurück zum Zitat Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625–1630CrossRefPubMed Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625–1630CrossRefPubMed
Zurück zum Zitat Salvatori L, Caporuscio F, Coroniti G, Starace G, Frati L, Russo MA, Petrangeli E (2009) Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. J Cell Physiol 220:35–44CrossRefPubMed Salvatori L, Caporuscio F, Coroniti G, Starace G, Frati L, Russo MA, Petrangeli E (2009) Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. J Cell Physiol 220:35–44CrossRefPubMed
Zurück zum Zitat Svoboda M, Hamilton G, Thalhammer T (2010) Steroid hormone metabolizing enzymes in benign and malignant human bone tumors. Expert Opin Drug Metab Toxicol 6:427–437CrossRefPubMed Svoboda M, Hamilton G, Thalhammer T (2010) Steroid hormone metabolizing enzymes in benign and malignant human bone tumors. Expert Opin Drug Metab Toxicol 6:427–437CrossRefPubMed
Zurück zum Zitat Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98–W102CrossRefPubMedPubMedCentral Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98–W102CrossRefPubMedPubMedCentral
Zurück zum Zitat Vinas-Castells R, Beltran M, Valls G, Gomez I, Garcia JM, Montserrat-Sentis B, Baulida J, Bonilla F, de Herreros AG, Diaz VM (2010) The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem 285:3794–3805CrossRefPubMed Vinas-Castells R, Beltran M, Valls G, Gomez I, Garcia JM, Montserrat-Sentis B, Baulida J, Bonilla F, de Herreros AG, Diaz VM (2010) The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem 285:3794–3805CrossRefPubMed
Zurück zum Zitat Vinas-Castells R, Frias A, Robles-Lanuza E, Zhang K, Longmore GD, Garcia de Herreros A, Diaz VM (2014) Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability. Nucleic Acids Res 42:1079–1094CrossRefPubMed Vinas-Castells R, Frias A, Robles-Lanuza E, Zhang K, Longmore GD, Garcia de Herreros A, Diaz VM (2014) Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability. Nucleic Acids Res 42:1079–1094CrossRefPubMed
Zurück zum Zitat Wei W, Chen ZJ, Zhang KS, Yang XL, Wu YM, Chen XH, Huang HB, Liu HL, Cai SH, Du J et al (2014) The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo. Cell Death Dis 5:e1428CrossRefPubMedPubMedCentral Wei W, Chen ZJ, Zhang KS, Yang XL, Wu YM, Chen XH, Huang HB, Liu HL, Cai SH, Du J et al (2014) The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo. Cell Death Dis 5:e1428CrossRefPubMedPubMedCentral
Zurück zum Zitat Yang M, Liu B, Jin L, Tao H, Yang Z (2017) Estrogen receptor beta exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway. J Bone Oncol 9:15–20CrossRefPubMedPubMedCentral Yang M, Liu B, Jin L, Tao H, Yang Z (2017) Estrogen receptor beta exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway. J Bone Oncol 9:15–20CrossRefPubMedPubMedCentral
Zurück zum Zitat Yen M-L, Chien C-C, Chiu I-M, Huang H-I, Chen Y-C, Hu H-I, Yen BL (2007) Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells (Dayt Ohio) 25:125–131CrossRef Yen M-L, Chien C-C, Chiu I-M, Huang H-I, Chen Y-C, Hu H-I, Yen BL (2007) Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells (Dayt Ohio) 25:125–131CrossRef
Zurück zum Zitat Zheng H, Shen M, Zha YL, Li W, Wei Y, Blanco MA, Ren G, Zhou T, Storz P, Wang HY et al (2014) PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell 26:358–373CrossRefPubMedPubMedCentral Zheng H, Shen M, Zha YL, Li W, Wei Y, Blanco MA, Ren G, Zhou T, Storz P, Wang HY et al (2014) PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer Cell 26:358–373CrossRefPubMedPubMedCentral
Zurück zum Zitat Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931–940CrossRefPubMed Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931–940CrossRefPubMed
Zurück zum Zitat Zhu G, Huang Y, Wu C, Wei D, Shi Y (2016) Activation of G-protein-coupled estrogen receptor inhibits the migration of human nonsmall cell lung cancer cells via IKK-beta/NF-kappaB signals. DNA Cell Biol 35:434–442CrossRefPubMed Zhu G, Huang Y, Wu C, Wei D, Shi Y (2016) Activation of G-protein-coupled estrogen receptor inhibits the migration of human nonsmall cell lung cancer cells via IKK-beta/NF-kappaB signals. DNA Cell Biol 35:434–442CrossRefPubMed
Metadaten
Titel
G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail
verfasst von
Zhen Wang
Xiao Chen
Yongqiang Zhao
Yi Jin
Jia Zheng
Publikationsdatum
20.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2019
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2768-4

Weitere Artikel der Ausgabe 1/2019

Journal of Cancer Research and Clinical Oncology 1/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.